Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

CERT

Certara Inc

May 31 • 04:00PM ET

16.95

Dollar change +0.05
Percentage change 0.30	%

Healthcare • Health Information Services • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: IJR VTI VB VBK VXF IJT IJS SCHA VIOO VHT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.39	Insider Own	31.83%	Shs Outstand	159.85M	Perf Week	2.54%
Market Cap	2.73B	Forward P/E	32.49	EPS next Y	0.52	Insider Trans	-0.07%	Shs Float	109.64M	Perf Month	-2.02%
Income	-61.40M	PEG	-	EPS next Q	0.10	Inst Own	69.63%	Short Float	5.17%	Perf Quarter	-7.38%
Sales	360.69M	P/S	7.56	EPS this Y	1.48%	Inst Trans	-1.85%	Short Ratio	10.52	Perf Half Y	16.57%
Book/sh	6.58	P/B	2.58	EPS next Y	19.56%	ROA	-3.95%	Short Interest	5.67M	Perf Year	-18.43%
Cash/sh	1.40	P/C	12.13	EPS next 5Y	34.70%	ROE	-5.74%	52W Range	11.81 - 22.65	Perf YTD	-3.64%
Dividend Est.	-	P/FCF	36.34	EPS past 5Y	-10.50%	ROI	-4.54%	52W High	-25.17%	Beta	1.59
Dividend TTM	-	Quick Ratio	3.26	Sales past 5Y	16.90%	Gross Margin	46.48%	52W Low	43.52%	ATR (14)	0.59
Dividend Ex-Date	-	Current Ratio	3.26	EPS Y/Y TTM	-538.07%	Oper. Margin	1.61%	RSI (14)	51.75	Volatility	2.89% 3.65%
Employees	1391	Debt/Eq	0.29	Sales Y/Y TTM	4.73%	Profit Margin	-17.02%	Recom	2.45	Target Price	19.72
Option/Short	Yes / Yes	LT Debt/Eq	0.28	EPS Q/Q	-445.88%	Payout	-	Rel Volume	0.92	Prev Close	16.90
Sales Surprise	3.22%	EPS Surprise	-2.91%	Sales Q/Q	7.04%	Earnings	May 07 AMC	Avg Volume	539.06K	Price	16.95
SMA20	1.03%	SMA50	-0.86%	SMA200	5.63%	Trades		Volume	494,795	Change	0.30%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$23
Apr-04-24	Initiated	JMP Securities	Mkt Perform
Feb-26-24	Initiated	Leerink Partners	Market Perform	$19
Dec-07-23	Initiated	UBS	Neutral	$17
Dec-05-23	Initiated	KeyBanc Capital Markets	Sector Weight
Aug-22-23	Downgrade	Jefferies	Buy → Hold	$24.50 → $17
Aug-10-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-12-23	Initiated	Stephens	Overweight	$28
Apr-03-23	Downgrade	Barclays	Overweight → Equal Weight	$25
Dec-14-22	Downgrade	Robert W. Baird	Outperform → Neutral	$17 → $19
Sep-08-22	Initiated	Berenberg	Buy	$23
Aug-25-22	Initiated	Credit Suisse	Outperform	$22
Jul-01-22	Initiated	Piper Sandler	Overweight	$28
Jan-11-22	Upgrade	Jefferies	Hold → Buy	$31
Aug-05-21	Resumed	Credit Suisse	Neutral	$36
Jul-23-21	Initiated	Robert W. Baird	Outperform	$30
Mar-03-21	Initiated	Barclays	Overweight	$40
Jan-06-21	Initiated	Morgan Stanley	Equal-Weight	$35
Jan-05-21	Initiated	William Blair	Outperform
Jan-05-21	Initiated	Jefferies	Hold	$33

Show Previous Ratings

May-29-24 04:15PM	Certara to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire)
May-21-24 08:00AM	Certara Appoints New Chief Human Resources Officer & General Counsel (GlobeNewswire)
May-09-24 02:45PM	Certara, Inc. (NASDAQ:CERT) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 01:16PM	Q1 2024 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -7.42%
05:48AM	Certara Q1 Adjusted Earnings Down, Revenue Increases (MT Newswires)
04:13AM	Loading…
04:13AM	Certara Inc (CERT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com)
May-07-24 06:40PM	Certara, Inc. (CERT) Q1 Earnings Meet Estimates (Zacks)
05:59PM	Certara Inc (CERT) Q1 2024 Earnings: Mixed Results Amidst Revenue Growth and Net Loss (GuruFocus.com)
04:15PM	Certara Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-06-24 03:19AM	What Makes Certara (CERT) an Attractive Bet? (Insider Monkey)
Apr-16-24 08:00AM	Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform (GlobeNewswire)
Apr-09-24 04:15PM	Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference (GlobeNewswire)
Apr-04-24 07:01PM	Insider Sell: President of Drug Dev Solutions at Certara Inc (CERT) Sells Shares (GuruFocus.com) +5.15%
Mar-02-24 08:41AM	Certara, Inc. (NASDAQ:CERT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 07:10AM	Q4 2023 Certara Inc Earnings Call (Thomson Reuters StreetEvents) +8.41%
06:05PM	Loading…
Feb-29-24 06:05PM	Certara, Inc. (CERT) Lags Q4 Earnings Estimates (Zacks)
04:52PM	Certara Inc (CERT) Reports Modest Revenue Growth Amidst Net Loss in Q4 2023 (GuruFocus.com)
04:10PM	Certara Reports Fourth Quarter 2023 Financial Results (GlobeNewswire)
Feb-01-24 04:30PM	Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference (GlobeNewswire)
Jan-31-24 11:03PM	Baillie Gifford Adjusts Position in Certara Inc (GuruFocus.com)
Dec-13-23 04:30PM	Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies (GlobeNewswire)
Nov-21-23 04:30PM	Certara introduces Simcyp Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development (GlobeNewswire)
Nov-10-23 01:22PM	Certara, Inc. (NASDAQ:CERT) Q3 2023 Earnings Call Transcript (Insider Monkey) +6.72%
Nov-09-23 10:41AM	Q3 2023 Certara Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-08-23 07:15PM	Certara, Inc. (CERT) Q3 Earnings Meet Estimates (Zacks)
04:10PM	Certara Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-31-23 12:00PM	Top 12 Medical AI Companies (Insider Monkey)
Oct-20-23 08:34AM	Are Options Traders Betting on a Big Move in Certara (CERT) Stock? (Zacks)
Oct-11-23 04:15PM	Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference (GlobeNewswire)
Sep-19-23 08:15AM	Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software (GlobeNewswire)
05:01AM	Loading…
Sep-13-23 05:01AM	Insider Sell: Leif Pedersen Sells 51,224 Shares of Certara Inc (CERT) (GuruFocus.com)
Aug-29-23 04:15PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
08:15AM	Certara Simcyp Group Awarded Two New Grants from US FDA (GlobeNewswire)
Aug-23-23 01:43PM	Analysts on Wall Street Lower Ratings for These 10 Stocks (Insider Monkey)
Aug-22-23 02:41AM	4 big analyst cuts: Target slashed to Neutral after Q2 Earnings (Investing.com)
Aug-12-23 08:07AM	Certara, Inc. (NASDAQ:CERT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report (Simply Wall St.)
Aug-11-23 06:09AM	Certara Second Quarter 2023 Earnings: Revenues Disappoint (Simply Wall St.)
Aug-10-23 09:41AM	Q2 2023 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -7.65%
Aug-09-23 04:15PM	Certara Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-03-23 09:00PM	Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset (Business Wire)
Aug-02-23 08:55AM	There's Been No Shortage Of Growth Recently For Certara's (NASDAQ:CERT) Returns On Capital (Simply Wall St.)
Jul-27-23 09:47AM	12 Best Growth Stocks Under $25 (Insider Monkey)
Jul-13-23 04:30PM	Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023 (GlobeNewswire)
Jun-02-23 04:15PM	Certara to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire)
May-16-23 06:50AM	Reasons to Invest in Certara (CERT) (Insider Monkey)
May-09-23 06:53AM	Q1 2023 Certara Inc Earnings Call (Thomson Reuters StreetEvents) -10.72%
May-08-23 06:35PM	Certara, Inc. (CERT) Matches Q1 Earnings Estimates (Zacks)
04:15PM	Certara Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-02-23 10:02AM	Guardant Health (GH) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
04:24AM	Factors to Note Ahead of Atlassian's (TEAM) Q3 Earnings Release (Zacks)
May-01-23 02:03PM	DraftKings (DKNG) to Report Q1 Earnings: What's in Store? (Zacks)
10:01AM	Certara, Inc. (CERT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
07:13AM	The Zacks Analyst Blog Highlights Shake Shack, Wingstop, AssetMark Financial, Primerica and Certara (Zacks)
Apr-28-23 07:15AM	5 Must-Buy High-Flying Mid-Cap Stocks Ahead of Q1 Earnings (Zacks)
Apr-27-23 08:00AM	Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year (GlobeNewswire)
Apr-10-23 04:30PM	Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference (GlobeNewswire)
Apr-06-23 12:19PM	MorphoSys Up on Finishing Early Enrolment in Myelofibrosis Study (Zacks)
Apr-05-23 12:25PM	AstraZeneca's (AZN) Drug Combo Meets Ovarian Cancer Study Goal (Zacks)
11:42AM	VBI Vaccines (VBIV) Down 53% on Initiating Restructuring Plans (Zacks)
Apr-04-23 12:43PM	Ascendis (ASND) Down on Hypoparathyroidism Drug NDA Deficiencies (Zacks)
Mar-29-23 12:01PM	Biomea (BMEA) Up 99% on Upbeat Data From Type II Diabetes Study (Zacks)
Mar-28-23 03:00PM	GSK's Jemperli Effective Against First-Line Endometrial Cancer (Zacks)
Mar-27-23 11:35AM	Iovance (IOVA) Completes Rolling BLA Filing for Melanoma Drug (Zacks)
Mar-15-23 05:41PM	Exponent Set to Join S&P MidCap 400; CVR Energy and Certara to Join S&P SmallCap 600 (PR Newswire)
10:00AM	Best Momentum Stocks to Buy for March 15th (Zacks)
Mar-14-23 09:40AM	Is Certara (CERT) Outperforming Other Medical Stocks This Year? (Zacks)
Mar-09-23 12:20PM	Can Certara, Inc. (CERT) Run Higher on Rising Earnings Estimates? (Zacks)
08:00AM	A.I. Coming to Certaras D360 Scientific Informatics Software (GlobeNewswire)
Mar-08-23 07:04AM	Certara, Inc. (NASDAQ:CERT) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 08:00AM	Certara announces the release of Simcyp PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types (GlobeNewswire)
Mar-02-23 07:43AM	Q4 2022 Certara Inc Earnings Call (Thomson Reuters StreetEvents) +17.30%
Mar-01-23 06:25PM	Certara, Inc. (CERT) Tops Q4 Earnings and Revenue Estimates (Zacks)
04:16PM	Certara Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
04:15PM	Certara Announces Transition Plan for Chief Financial Officer (GlobeNewswire)
Feb-27-23 04:30PM	Certara to Participate in the Barclays Global Healthcare Conference (GlobeNewswire)
Feb-01-23 04:30PM	Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023 (GlobeNewswire)
Jan-09-23 11:40AM	CERT vs. PBYI: Which Stock Should Value Investors Buy Now? (Zacks)
Jan-04-23 07:31AM	Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation (GlobeNewswire)
Dec-23-22 06:35PM	Freshpet and Peabody Energy Stock See Action From Activist Investors (Barrons.com)
Dec-08-22 04:30PM	Certara Announces the Completion of Arsenal Capital Partners Investment and the Appointment of David Spaight to the Board of Directors (GlobeNewswire)
Nov-26-22 09:01PM	Certara (CERT) Stock Dropped in the Third Quarter on Earnings Guidance (Insider Monkey)
Nov-11-22 04:28PM	Why Certara's Shares Rose 37.7% This Week (Motley Fool)
Nov-07-22 07:05PM	Certara, Inc. (CERT) Q3 Earnings Miss Estimates (Zacks) +19.58%
04:15PM	Certara Reports Third Quarter 2022 Financial Results (GlobeNewswire)
08:00AM	Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase (GlobeNewswire)
Nov-02-22 05:00PM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire) -5.36%
Oct-19-22 08:00AM	Japans Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certaras Software for Evaluating Regulatory Submissions (GlobeNewswire) -7.40%
Oct-13-22 07:45AM	Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022 (GlobeNewswire)
Aug-31-22 08:00AM	Certara to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-11-22 04:38PM	Certara Announces Secondary Offering (GlobeNewswire)
Aug-09-22 09:00PM	Certara, Inc. (CERT) Q2 2022 Earnings Call Transcript (Motley Fool) -5.35%
07:45PM	Certara, Inc. (CERT) Q2 Earnings and Revenues Miss Estimates (Zacks)
05:00PM	Edited Transcript of CERT.OQ earnings conference call or presentation 9-Aug-22 9:00pm GMT (Thomson Reuters StreetEvents)
04:15PM	Certara Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-05-22 08:00AM	Certara Introduces Update of Pinnacle 21 Enterprise and New Pinnacle 21 Data Exchange Module (GlobeNewswire)
Aug-01-22 03:02PM	Can Virtual Patients Lead to Better Cell Therapies? (TheStreet.com)
Jul-28-22 08:00AM	Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies (GlobeNewswire)
Jul-25-22 08:00AM	Certara Appoints Rosemary Crane as New Independent Board Member (GlobeNewswire)
Jul-13-22 08:00AM	Certara Appoints Eran Broshy as New Independent Board Member (GlobeNewswire)
Jul-12-22 08:00AM	Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022 (GlobeNewswire)

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Princeton, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WALSH MATTHEW M	Director	May 21 '24	Option Exercise	0.00	8,663	0	185,631	May 23 04:45 PM
Killefer Nancy	Director	May 21 '24	Option Exercise	0.00	8,663	0	24,161	May 23 04:40 PM
Crane Rosemary A	Director	May 21 '24	Option Exercise	0.00	8,663	0	17,987	May 23 04:35 PM
Collins Cynthia	Director	May 21 '24	Option Exercise	0.00	8,663	0	24,161	May 23 04:29 PM
CASHMAN JAMES E III	Chairman	May 21 '24	Option Exercise	0.00	8,663	0	456,512	May 23 04:22 PM
BROSHY ERAN	Director	May 21 '24	Option Exercise	0.00	8,663	0	23,023	May 23 04:17 PM
SMITH PATRICK F	PRESIDENT, DRUG DEV SOLUTIONS	Apr 02 '24	Sale	16.85	14,427	243,161	50,091	Apr 04 04:45 PM
Traynor Richard M.	SVP AND GENERAL COUNSEL	Apr 01 '24	Option Exercise	0.00	13,295	0	178,800	Apr 03 05:08 PM
SMITH PATRICK F	PRESIDENT, DRUG DEV SOLUTIONS	Apr 01 '24	Option Exercise	0.00	16,498	0	67,208	Apr 03 05:07 PM
SHERMAN NICOLETTE D	CHIEF HUMAN RESOURCES OFFICER	Apr 01 '24	Option Exercise	0.00	8,219	0	25,684	Apr 03 05:05 PM
Pedersen Leif E	PRESIDENT, CHIEF COMMERCAL OFF	Apr 01 '24	Option Exercise	0.00	16,498	0	152,840	Apr 03 05:03 PM
Gallagher John E	CHIEF FINANCIAL OFFICER	Apr 01 '24	Option Exercise	0.00	27,295	0	22,545	Apr 03 05:02 PM
Aspbury Robert	PRESIDENT; SCIENTIFIC SOFTWARE	Apr 01 '24	Option Exercise	0.00	16,498	0	293,867	Apr 03 05:00 PM
Feehery William F	CHIEF EXECUTIVE OFFICER	Apr 01 '24	Option Exercise	0.00	69,799	0	2,263,269	Apr 03 04:44 PM
Traynor Richard M.	SVP AND GENERAL COUNSEL	Apr 01 '24	Sale	18.00	3,000	54,000	173,524	Apr 03 05:08 PM
Traynor Richard M.	SVP AND GENERAL COUNSEL	Mar 04 '24	Sale	18.28	3,000	54,840	162,368	Mar 05 04:45 PM
SMITH PATRICK F	PRESIDENT, DRUG DEV SOLUTIONS	Feb 20 '24	Sale	18.00	5,000	90,000	54,975	Feb 21 04:40 PM
Traynor Richard M.	SVP AND GENERAL COUNSEL	Feb 12 '24	Sale	18.00	6,000	108,000	165,368	Feb 14 04:33 PM
Traynor Richard M.	SVP AND GENERAL COUNSEL	Dec 26 '23	Sale	18.00	6,000	108,000	171,368	Dec 27 06:36 PM
Pedersen Leif E	PRESIDENT, CHIEF COMMERCAL OFF	Sep 11 '23	Sale	14.60	51,224	747,870	128,883	Sep 12 04:26 PM
BROSHY ERAN	Director	Aug 22 '23	Buy	15.80	4,807	75,951	14,360	Aug 23 04:38 PM
BROSHY ERAN	Director	Aug 21 '23	Buy	16.10	193	3,107	9,553	Aug 23 04:38 PM
SMITH PATRICK F	PRESIDENT, INTEGRATED DRUG DEV	Jun 05 '23	Sale	21.55	19,104	411,691	59,975	Jun 06 04:56 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CERT

Certara Inc

Upgrade your FINVIZ experience